Advertisement
News
Advertisement

Forest Labs says Bystolic approved in Canada

Thu, 01/17/2013 - 5:53pm
The Associated Press

Forest Laboratories Inc. said Thursday that Canadian regulators approved its high blood pressure drug Bystolic.

Forest said Bystolic will be available in Canada starting in the second quarter. In Forest's latest fiscal quarter, worldwide sales of Bystolic rose 20 percent to $108.8 million.

Shares of Forest rose 45 cents to $37.02 on Thursday, and gave up a penny to $37.01 in aftermarket trading.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading